Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial – The Lancet Invited Commentary: Azithromycin for severe COVID-19   Commentaries on Twitter This network of Brazilian researchers has done an AMAZING job […]

The post Coalition Covid-19 Brazil – Randomized trial: Azithromycin not beneficial for patients admitted to the hospital with severe Covid-19 appeared first on Links Medicus.